Engineering cancer resistance in mice

Peter Klatt1, Manuel Serrano

  • 1Spanish National Centre of Biotechnology, Department of Immunology and Oncology, Campus de Cantoblanco, Madrid E-28049, Spain.

Carcinogenesis
|May 29, 2003
PubMed

Insights

Engineering mice for cancer resistance is a novel research area. This review examines models of cancer resistance in mice, focusing on molecular mechanisms and potential health impacts.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Genetic manipulation of mice has significantly advanced cancer research.
  • Previous research focused on accelerating tumorigenesis or modeling cancer development.
  • A novel approach involves engineering mice for cancer resistance to understand susceptibility.

Purpose of the Study:

  • To review existing mouse models exhibiting a cancer resistance phenotype.
  • To emphasize the molecular underpinnings of cancer resistance.
  • To identify associated phenotypes that could negatively affect health.

Main Methods:

  • Literature review of published studies on cancer-resistant mouse models.
  • Analysis of genetic modifications and their impact on tumorigenesis.
  • Evaluation of associated health phenotypes in engineered mice.

Main Results:

  • Several mouse models with inherent or engineered cancer resistance have been described.
  • The molecular basis for resistance varies across different models.
  • Associated phenotypes, potentially detrimental to health, are frequently observed.

Conclusions:

  • Cancer-resistant mouse models offer valuable insights into cancer susceptibility.
  • These models are crucial for validating therapeutic and chemopreventive strategies.
  • Further research is needed to balance cancer resistance with overall health in these models.